Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clifford Bryant

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters|September 24, 2009
Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteasesClifford Bryant, Iain D Kerr, Moumita Debnath, et al.
Cell Chemical Biology|July 19, 2024
Development of covalent chemogenetic K<sub>2P</sub> channel activatorsParker E Deal, Haerim Lee, Abhisek Mondal, et al.
Journal of the American Chemical Society|April 27, 2023
Engaging a Non-catalytic Cysteine Residue Drives Potent and Selective Inhibition of Caspase-6Kurt S Van Horn, Dongju Wang, Daniel Medina-Cleghorn, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 23, 2013
Biaryl amides and hydrazones as therapeutics for prion disease in transgenic miceDuo Lu, Kurt Giles, Zhe Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 31, 2015
Different 2-Aminothiazole Therapeutics Produce Distinct Patterns of Scrapie Prion Neuropathology in Mouse BrainsKurt Giles, David B Berry, Carlo Condello, et al.
Journal of Biomolecular Screening|October 5, 2014
Lead identification to clinical candidate selection: drugs for Chagas diseaseR Jeffrey Neitz, Steven Chen, Frantisek Supek, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide LeadsEmma L Gunderson, Clifford Bryant, Christina A Bulman, et al.
Beilstein Journal of Organic Chemistry|February 13, 2013
Chemical-biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-targetJonathan W Choy, Clifford Bryant, Claudia M Calvet, et al.
Journal of Medicinal Chemistry|November 24, 2005
Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin KJames T Palmer, Clifford Bryant, Dan-Xiong Wang, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters|September 24, 2009
Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteasesClifford Bryant, Iain D Kerr, Moumita Debnath, et al.
Cell Chemical Biology|July 19, 2024
Development of covalent chemogenetic K<sub>2P</sub> channel activatorsParker E Deal, Haerim Lee, Abhisek Mondal, et al.
Journal of the American Chemical Society|April 27, 2023
Engaging a Non-catalytic Cysteine Residue Drives Potent and Selective Inhibition of Caspase-6Kurt S Van Horn, Dongju Wang, Daniel Medina-Cleghorn, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 23, 2013
Biaryl amides and hydrazones as therapeutics for prion disease in transgenic miceDuo Lu, Kurt Giles, Zhe Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 31, 2015
Different 2-Aminothiazole Therapeutics Produce Distinct Patterns of Scrapie Prion Neuropathology in Mouse BrainsKurt Giles, David B Berry, Carlo Condello, et al.
Journal of Biomolecular Screening|October 5, 2014
Lead identification to clinical candidate selection: drugs for Chagas diseaseR Jeffrey Neitz, Steven Chen, Frantisek Supek, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide LeadsEmma L Gunderson, Clifford Bryant, Christina A Bulman, et al.
Beilstein Journal of Organic Chemistry|February 13, 2013
Chemical-biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-targetJonathan W Choy, Clifford Bryant, Claudia M Calvet, et al.
Journal of Medicinal Chemistry|November 24, 2005
Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin KJames T Palmer, Clifford Bryant, Dan-Xiong Wang, et al.
Pageof 2